"If you focus on the enterprise segments, then all of the AI solutions that they're building still need to be evaluated, ...

To keep up with COPD research and care developments, the 2026 Global Initiative for Chronic Obstructive Lung Disease report ...

The latest update is out from Beamr Imaging Ltd. ( (BMR) ).

A Scalable, Secure Platform Accelerating the Development of AI in Medical Imaging New platform unites HOPPR says its new AI ...

During an exclusive behind-the-scenes event at OPPO's global headquarters and R&D hub at the Binhai Bay Campus, OPPO unveiled its vision for next-level quality: embedding its commitment to quality ...

Leading Edge Health's GenuinePurity brand addresses authentication challenges and bioavailability concerns with certificate ...

OCO’s e-learning course is designed to make AI and AI quality assurance and testing practical and understandable.

By re-imagining internal audit as a real-time strategic partner, companies can move from reacting after the fact to detecting ...

In this interview, Dr. Anderson discusses the advantages of dd-cfDNA as a transplant monitoring tool and the regulatory and ...

The HOPPR (TM) AI Foundry is purpose-built for the complexities of healthcare and medical imaging, offering the tools, data, and compliance frameworks developers need to create reliable, ...

in people with antiphospholipid syndrome (APS). It awaits prospective validation, but could be useful to help measure activity as opposed to severity – tracking symptoms over time, both in clinical ...

These subgroup insights will guide trial design, patient selection, and endpoint strategy for Autonomix's upcoming U.S.-based multicenter clinical study, currently planned to begin in 2026, which will ...